Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.

Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.

Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, Rafii S.

Ann N Y Acad Sci. 2001 Jun;938:36-45; discussion 45-7.

PMID:
11458524
2.

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S.

J Exp Med. 2001 May 7;193(9):1005-14.

3.

Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.

Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA.

Blood. 2001 Jun 1;97(11):3354-60.

6.

Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.

de Bont ES, Guikema JE, Scherpen F, Meeuwsen T, Kamps WA, Vellenga E, Bos NA.

Cancer Res. 2001 Oct 15;61(20):7654-9.

7.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

8.
9.

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S.

Blood. 2003 Aug 15;102(4):1340-6. Epub 2003 Apr 17. Erratum in: Blood. 2004 Jun 15;103(12):4388.

11.
12.

Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow.

Dührsen U, Martinez T, Vohwinkel G, Ergün S, Sun L, McMahon G, Dürig J, Hossfeld DK, Fiedler W.

Growth Factors. 2001;19(1):1-17.

PMID:
11678206
14.
15.

S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.

Ryser MF, Ugarte F, Lehmann R, Bornhäuser M, Brenner S.

Mol Immunol. 2008 Nov;46(1):166-71. doi: 10.1016/j.molimm.2008.07.016. Epub 2008 Aug 29.

PMID:
18760838
16.

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.

Hidalgo A, Sanz-Rodríguez F, Rodríguez-Fernández JL, Albella B, Blaya C, Wright N, Cabañas C, Prósper F, Gutierrez-Ramos JC, Teixidó J.

Exp Hematol. 2001 Mar;29(3):345-55.

PMID:
11274763
17.

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.

Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T.

Circulation. 2003 Mar 11;107(9):1322-8.

18.

In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells.

Huang XL, Takakura N, Suda T.

Biochem Biophys Res Commun. 1999 Oct 14;264(1):133-8.

PMID:
10527853
19.
20.

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M.

Blood. 2004 Dec 1;104(12):3472-82. Epub 2004 Jul 29.

Supplemental Content

Support Center